zoledronic acid fresenius kabi 4 mg / 5 ml infuusiokonsentraatti, liuosta varten
fresenius kabi ab - zoledronic acid monohydrate - infuusiokonsentraatti, liuosta varten - 4 mg / 5 ml - tsoledronihappo
zoledronic acid sandoz 4 mg / 5 ml infuusiokonsentraatti, liuosta varten
sandoz a/s - zoledronic acid monohydrate - infuusiokonsentraatti, liuosta varten - 4 mg / 5 ml - tsoledronihappo
zoledronic acid sandoz 4 mg / 100 ml infuusioneste, liuos
sandoz a/s - zoledronic acid monohydrate - infuusioneste, liuos - 4 mg / 100 ml - tsoledronihappo
zoledronic acid sun 5 mg infuusioneste, liuos
sun pharmaceutical industries b.v. - zoledronic acid monohydrate - infuusioneste, liuos - 5 mg - tsoledronihappo
zoledronic acid stada 4 mg / 100 ml infuusioneste, liuos
stada arzneimittel ag - zoledronic acid monohydrate - infuusioneste, liuos - 4 mg / 100 ml - tsoledronihappo
zoledronic acid oresund pharma 4 mg / 100 ml infuusioneste, liuos
oresund pharma aps - zoledronic acid monohydrate - infuusioneste, liuos - 4 mg / 100 ml - tsoledronihappo
zoledronic acid oresund pharma 5 mg / 100 ml infuusioneste, liuos
oresund pharma aps - zoledronic acid monohydrate - infuusioneste, liuos - 5 mg / 100 ml - tsoledronihappo
zoledronic acid fair-med 5 mg / 100 ml infuusioneste, liuos
fair-med healthcare gmbh - happo zoledronicum monohydricum - infuusioneste, liuos - 5 mg / 100 ml - tsoledronihappo
zoledronic acid sandoz 5 mg / 100 ml infuusioneste, liuos
sandoz a/s sandoz a/s - happo zoledronicum - infuusioneste, liuos - 5 mg / 100 ml - tsoledronihappo
zoledronic acid teva pharma
teva b.v. - zoledronihappoa - osteoporosis; osteitis deformans; osteoporosis, postmenopausal - lääkkeet luusairauksien hoitoon - treatment of osteoporosis: , in post-menopausal women;, in men; , at increased risk of fracture including those with a recent low-trauma hip fracture. treatment of osteoporosis associated with long-term systemic glucocorticoid therapy: , in post-menopausal women;, in men; , at increased risk of fracture. hoitoon pagetin tauti luu aikuisilla.